| Description | Telitacicept (RC18), a fully human TACI-Fc fusion protein, acts as a dual inhibitor of B lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand), effectively impeding B lymphocyte proliferation. This compound is applicable in researching B-cell autoimmune diseases [1]. |
| Synonyms | RC18 |
| molecular weight | N/A |
| CAS | 2136630-26-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |